Women's Recovery Group (WRG) Study - A Randomized Controlled Stage II Trial
Completed · Not applicable
Conditions studied: Substance-Related Disorders, Alcohol-Related Disorders
In brief
The purpose of this Stage II randomized controlled behavioral treatment development trial was to test the effectiveness of the Women's Recovery Group (WRG) relative to mixed-gender Group Drug Counseling (GDC) and demonstrate the feasibility of implementing the WRG in an open-enrollment (i.e., rolling admission) group format at two clinical sites. The Stage II trial aims were to (1) investigate effectiveness of the WRG relative to GDC in a sample of women heterogeneous with respect to substance use and co-occurring psychiatric disorders, and (2) demonstrate the feasibility of implementing WRG in an open enrollment group format characteristic of community treatment programs at two sites.
Key facts
- Study ID
- NCT01318538
- Run by
- Mclean Hospital
- People needed
- 158
- Starts
- 2008-08-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2017-06-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects were included in the study if they:
- were 18 years or older
- used substances within the past 60 days
- met current Diagnostic and Statistical Manual (DSM)-IV criteria (American Psychiatric Association, 2000; World Health Organization, 1997) of substance dependence (in addition to any nicotine dependence)
- planned to stay within the area during the study period
- consented for study personnel to communicate with other mental health professionals from whom they are receiving care
- furnished the names of two locators who can assist study personnel in locating them during the study period
- were interested in group treatment
- lived close enough either to McLean Hospital or SSTAR to come to group weekly
- were able to sign informed consent.
You may not qualify if…
- Patients were excluded if they:
- had a current medical condition that would prevent regular group attendance
- had mental retardation or organic mental disorder
- had certain other major Axis I psychiatric disorders according to the Composite International Diagnostic Interview (CIDI), such as psychotic disorders or bipolar I disorder
- would be in a residential treatment setting throughout the treatment period in which substance use is monitored and restricted (e.g., a therapeutic community)
- required medical detoxification (these patients could enter the study after being detoxified)
- were current intravenous drug users
- engaged in self-destructive behaviors (e.g., life-threatening bulimia or anorexia, suicide attempts and chronic suicidality) or other behaviors (e.g., violence toward others, assault behaviors)
Where it is running
- McLean Hospital — Belmont, Massachusetts, United States
- Stanley Street Treatment and Resources (SSTAR) — Fall River, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.